Mr. Closner is the CEO and a founder of the Company. Since its inception, Neil has been a key driver in the Company’s growth and vision. His responsibilities include oversight of all general management for the organization, strategic leadership on growth opportunities and fostering an entrepreneurial spirit throughout the Company. Neil brings nearly two decades of start-up, technology and health care experience to the MedReleaf team. Most recently, he was a member of the senior leadership team at Toronto’s Mount Sinai Hospital where he served as Vice President of Business Development. Neil began his career as a health-care focusedÂ investment banker with Salomon Smith Barney (now Citigroup) and has also served as the founder, CEO or on the board of directors for more than half a dozen technology and health-care related start-up companies. Neil is Chairman of the Board of Cannabis Canada Association, representing the majority of Licensed Producers. He also sits on the executive committee and on the board of directors of Technion Canada. Neil studied economics at the London School of Economics and Political Science in London, England, attained a B.A. from McGill University and an MBA from the Wharton School at the University of Pennsylvania.